Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Jürgen Debus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6411-4811; OpenAlex author ID A5078003238, A5112706589. Sources: OpenAlex.

Their work

Papers
39 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
55
Papers, trials and grants by year

2011: 2 papers · 2012: 6 papers · 2013: 8 papers · 2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 4 papers · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 39

  1. Superior tumor cell killing by oxygen ion beam irradiation compared to carbon ions and photons in pancreatic Cancer cells - An in vitro investigation. Co-author DOI 10.1016/j.ctro.2026.101225↗
  2. Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Co-author DOI 10.1016/j.radonc.2026.111836↗
  3. Investigating LETd optimization strategies in carbon ion radiotherapy for pancreatic cancer: a dosimetric study using an anthropomorphic phantom. Co-author DOI 10.1002/mp.17569↗
  4. First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy Co-author DOI 10.1016/j.phro.2025.100803↗
  5. Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. Co-author DOI 10.3390/cancers16081497↗
  6. Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer. Co-author DOI 10.1007/s00066-021-01827-9↗
  7. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open rand… Co-author DOI 10.1186/s13014-022-01988-6↗
  8. Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.708884↗
  9. Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer. Co-author DOI 10.3390/cancers13040796↗
  10. Carbon ion radiotherapy in pancreatic cancer: A review of clinical data. Co-author DOI 10.1016/j.radonc.2020.05.012↗
  11. Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line. Co-author DOI 10.1038/s41598-020-57456-2↗
  12. Radiographic Response of Vessel Involvement and Resectability After Neoadjuvant Chemoradiation in Patients With Locally Advanced Pancreatic Cancer. Last author DOI 10.1097/coc.0000000000000746↗
  13. Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study. Co-author DOI 10.1186/s12885-020-07434-8↗
  14. Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation. Co-author DOI 10.3390/cancers11050709↗
  15. Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation. Co-author DOI 10.3390/cancers11111655↗
  16. Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0180940↗
  17. Phytotherapeutics Oridonin and Ponicidin show Additive Effects Combined with Irradiation in Pancreatic Cancer in Vitro. Co-author DOI 10.1515/raon-2017-0048↗
  18. Changes in Gross Tumor Volume and Organ Motion Analysis During Neoadjuvant Radiochemotherapy in Patients With Locally Advanced Pancreatic Cancer Using an In-Ho… Co-author DOI 10.1177/1533034615577515↗
  19. Optimization of Carbon Ion Treatment Plans by Integrating Tissue Specific α/β-Values for Patients with Non-Resectable Pancreatic Cancer. Co-author DOI 10.1371/journal.pone.0164473↗
  20. Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma. Co-author DOI 10.1186/s12957-015-0560-3↗
  21. Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer. Co-author DOI 10.1186/s13014-015-0538-x↗
  22. Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group. Co-author DOI 10.1186/2047-783x-19-24↗
  23. Prognostic impact of CA 19-9 on outcome after neoadjuvant chemoradiation in patients with locally advanced pancreatic cancer. Last author DOI 10.1245/s10434-014-3607-8↗
  24. Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comp… Last author DOI 10.1007/s00066-013-0391-5↗
  25. Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer. Co-author DOI 10.1007/s00066-013-0393-3↗
  26. Improvement of surgical results for pancreatic cancer. Co-author DOI 10.1016/s1470-2045(13)70172-4↗
  27. In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines. Co-author DOI 10.1093/jrr/rrt052↗
  28. Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial. Last author DOI 10.1186/1471-2407-13-419↗
  29. Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanc… Co-author DOI 10.1186/1748-717x-8-138↗
  30. Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Co-author DOI 10.1186/1748-717x-8-27↗
  31. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Co-author DOI 10.1245/s10434-012-2762-z↗
  32. [Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer]. Co-author DOI 10.1007/s00066-012-0214-0↗
  33. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer. Co-author DOI 10.1016/j.surg.2012.05.029↗
  34. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) i… Co-author DOI 10.1186/1471-2407-12-112↗
  35. Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospectiv… Co-author DOI 10.1186/1471-2407-12-295↗
  36. Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Co-author DOI 10.1186/1748-717x-7-28↗
  37. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with r… Co-author DOI 10.1200/jco.2011.38.2960↗
  38. [Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer]. Last author DOI 10.1007/s00104-011-2129-1↗
  39. Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. Co-author DOI 10.1186/1471-2407-11-134↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jakob Liermann · 13 shared papers, 2017–2026 · strength 2.06
  2. Patrick Naumann · 13 shared papers, 2013–2026 · strength 1.53
  3. Klaus K Herfarth · 7 shared papers, 2020–2026 · strength 1.15
  4. Andrea Mairani · 5 shared papers, 2013–2026 · strength 0.95
  5. Stephanie Elisabeth Combs · 17 shared papers, 2011–2019 · strength 0.86
  6. Daniel Habermehl · 15 shared papers, 2011–2016 · strength 0.64
  7. Filipa Baltazar · 2 shared papers, 2025–2026 · strength 0.50
  8. Jens Werner · 13 shared papers, 2011–2015 · strength 0.45
  9. Thilo Hackert · 6 shared papers, 2012–2020 · strength 0.43
  10. Ivana Đokić · 2 shared papers, 2024–2025 · strength 0.42
  11. Edgar Ben‐Josef · 3 shared papers, 2020–2022 · strength 0.42
  12. Markus Wolfgang Büchler · 11 shared papers, 2011–2015 · strength 0.39
  13. Peter Ernst Huber · 4 shared papers, 2011–2026 · strength 0.34
  14. Manuel Röhrich · 2 shared papers, 2021–2026 · strength 0.34
  15. Dirk Jäger · 8 shared papers, 2012–2015 · strength 0.30
  16. Christoph Springfeld · 2 shared papers, 2015–2026 · strength 0.28
  17. Christina Stengl · 1 shared paper, 2025 · strength 0.27
  18. Jonathan M. Schneeweiss · 1 shared paper, 2026 · strength 0.26
  19. Lixin Mai · 1 shared paper, 2026 · strength 0.26
  20. Stefan Rieken · 5 shared papers, 2012–2020 · strength 0.26
  21. Kerstin Anne Kessel · 6 shared papers, 2012–2016 · strength 0.24
  22. Christoph Michalski · 1 shared paper, 2026 · strength 0.23
  23. Semi Harrabi · 1 shared paper, 2026 · strength 0.23
  24. Bahar Cepni · 1 shared paper, 2024 · strength 0.21
  25. Celine Karle · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.